Go to:
Logótipo
You are here: Start > Publications > View > Nanomaterials in cancer: Reviewing the combination of hyperthermia and triggered chemotherapy
Today is sunday
Programa de formação da Biblioteca para o primeiro semestre já está disponível
Publication

Nanomaterials in cancer: Reviewing the combination of hyperthermia and triggered chemotherapy

Title
Nanomaterials in cancer: Reviewing the combination of hyperthermia and triggered chemotherapy
Type
Article in International Scientific Journal
Year
2022
Authors
Ribeiro, PT
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Agostinho Moreira, JA
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Monterio, JF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Laranjeira, SM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 347
Pages: 89-103
ISSN: 0168-3659
Publisher: Elsevier
Other information
Authenticus ID: P-00W-J1M
Abstract (EN): Nanoparticle mediated hyperthermia has been explored as a method to increase cancer treatment efficacy by heating tumours inside-out. With that purpose, nanoparticles have been designed and their properties tailored to respond to external stimuli and convert the supplied energy into heat, therefore inducing damage to tumour cells. Moreover, the combination of hyperthermia with chemotherapy has been described as a more effective strategy due to the synergy between the high temperature and the drug's effects, also associated with a remote controlled and on-demand drug release. In this review, the methods behind nanoparticle mediated hyperthermia, namely material design, external stimuli response and energy conversion will be discussed and critically analysed. We will address the most relevant studies on hyperthermia and temperature triggered drug release for cancer treatment. Finally, the advantages, difficulties and challenges of this therapeutic strategy will be discussed, while giving insight for future developments.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Sustained drug release by contact lenses for glaucoma treatment-A review (2015)
Another Publication in an International Scientific Journal
Carvalho, IM; Marques, CS; Oliveira, RS; Coelho, PB; Costa, PC; Ferreira, DC
Pluronic (R) triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview (2023)
Another Publication in an International Scientific Journal
de Castro, KC; Coco, JC; dos Santos, EM; Ataide, JA; Martinez, RM; do Nascimento, MHM; Prata, J; da Fonte, PRML; Severino, P; Mazzola, PG; Baby, AR; Souto, EB; de Araujo, DR; Lopes, AM
Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis (2019)
Another Publication in an International Scientific Journal
Costa, C; Moreira, JN; Maria Helena Amaral; Sousa Lobo JM; Silva, AC
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies (2020)
Another Publication in an International Scientific Journal
Marques, AC; Paulo Costa; Velho, S; Maria Helena Amaral
Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery (2016)
Another Publication in an International Scientific Journal
Fonte, P; Salette Reis; Sarmento, B

See all (24)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Engenharia da Universidade do Porto  I Terms and Conditions  I Accessibility  I Index A-Z  I Guest Book
Page generated on: 2024-11-03 at 06:54:48 | Acceptable Use Policy | Data Protection Policy | Complaint Portal